Fexinidazole is an antiparasitic agent. It has activity against Trypanosoma cruzi, Tritrichomonas foetus, Trichomonas vaginalis, Entamoeba histolytica, Trypanosoma brucei, and Leishmania donovani. The biologically relevant active metabolites in vivo are the sulfoxide and sulfone.
More Information Supplier Page
Fexinidazole is an antiparasitic agent. It has activity against Trypanosoma cruzi, Tritrichomonas foetus, Trichomonas vaginalis, Entamoeba histolytica, Trypanosoma brucei, and Leishmania donovani. The biologically relevant active metabolites in vivo are the sulfoxide and sulfone.
More Information Supplier Page 
2, 3-Butanedione 2-Monoxime is an inhibitor of skeletal and cardiac muscle contraction.
More Information Supplier Page
Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in Clinicalal development for acute decompensated heart failure.
More Information Supplier Page
Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in Clinicalal development for acute decompensated heart failure.
More Information Supplier Page Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in Clinicalal development for acute decompensated heart failure.
More Information Supplier Page 
3-AP (Triapine) is a novel inhibitor of the M2 subunit of ribonucleotide reductase (RR).
More Information Supplier Page
3-AP (Triapine) is a novel inhibitor of the M2 subunit of ribonucleotide reductase (RR).
More Information Supplier Page 3-AP (Triapine) is a novel inhibitor of the M2 subunit of ribonucleotide reductase (RR).
More Information Supplier Page 3-AP (Triapine) is a novel inhibitor of the M2 subunit of ribonucleotide reductase (RR).
More Information Supplier Page 
